FERMENTALG overview

Libourne, April 1, 2025 – Fermentalg, a key player in bio-solutions based on aquatic microorganisms, announces a 36% increase in its revenue for the first quarter of 2025, reaching €3.6 million compared to €2.7 million in the same period last year. This growth is largely due to the success of the company's strategy to expand its commercial opportunities into new market segments. Successful diversification The increasing risks to the availability of fish-derived omega-3s and the challenges...

Libourne, March 20, 2025 - Fermentalg, a key player in bio-solutions based on aquatic micro-organisms, presents its 2024 financial results after the accounts were approved by the Board of Directors on March 20, 2025 under the chairmanship of Philippe Lavielle. [1] Pierre Josselin, CEO of Fermentalg, says: " One year after launching our company transformation plan, [2] 2024 has clearly seen solid progress towards our goal of becoming a profitable and competitive industrial player by 2026. From a...

Libourne, March 10, 2025 - Fermentalg, an expert in the research and bioindustrial exploitation of microalgae, updates its financial communication calendar. Date Nature January 14, 2025 4 th quarter 2024 financial information (after market close) March 20, 2025 Annual results 2024 (after market close) April 1, 2025 Financial information for 1 st quarter 2025 (after market close) April 1, 2025 Webinar open to all investors (after market close) April 2, 2025 Investor Access Forum (Paris) [1] May...

Libourne, February 13, 2025 - Fermentalg, a key player in bio-solutions based on aquatic micro-organisms, proudly announces three major milestones reinforcing its commitment to food safety, sustainability, and innovation. Strengthening trust and excellence with FSSC 22000 certification Fermentalg is proud to have obtained the FSSC 22000 certification, an internationally recognized standard for food safety management. This milestone demonstrates our firm dedication to ensuring product quality,...

Libourne, February 6, 2024 - Fermentalg, a key player in bio-solutions based on aquatic micro-organisms, today unveils the progress of its strategic transformation initiated a year ago under the impetus of its CEO, Pierre Josselin. With 15 years of expertise in biotechnology, Fermentalg has established itself as a key player in the creation of natural bio-solutions based on aquatic micro-organisms, responding to the challenges of global health ( One Health ) and sustainable development, with a...

Libourne - January 15, 2025 - Fermentalg (Euronext Growth / ALGAE) publishes its financial agenda for the year 2024. Date Nature January 14, 2025 2024 Four quarter financial information (after market closing) March 20, 2025 2024 Annual results (after market closing) April 2, 2025 2025 First quarter financial information (after market closing) July 8, 2025 2025 Second quarter financial information (after market closing) Septembre 11, 2025 2025 Half-year results (after market closing) Octobre 7,...

Libourne - January 14, 2025 - Fermentalg (Euronext Growth / ALGAE) announces record annual sales for 2024 [1] and confirms its growth trajectory to reach profitability by 2026. Sales multiplied by almost 3 in 1 year Fermentalg closed a record 2024 financial year in terms of sales, with sales of €11.5 million, significantly higher than those of 2023 (€4 million) and the target set at the beginning of last year (€10 million). This performance is all the more remarkable given that Fermentalg...

Libourne - October 7, 2024 - Fermentalg (Euronext Growth / ALGAE), expert French microalgae specialist, is proud to have once again been recognized by EthiFinance and EcoVadis for the quality of its extra-financial performance. First in EthiFinance's sector ranking As every year, Fermentalg has been evaluated by EthiFinance ESG Ratings, the agency specialized in rating the ESG performance of small and medium-sized companies listed on European markets. Under EthiFinance ESG Ratings 2024,...